Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors
Lunit, a leading medical AI provider, today announced it has raised $61 million in its Pre-IPO fundraising […]
Female-Owned Biotech Startup Tiamat Sciences Raises $3 Million to Manufacture Plant-Based Biomolecules
Biotechnology startup Tiamat Sciences today announced its $3 million seed financing round led by Silicon Valley venture […]
Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round
Allorion Therapeutics, a company focusing on next-generation precision medicine for oncology and autoimmune disease, today […]
LoQus23 Therapeutics Exits Stealth with £11.5 Million Seed Financing from the Dementia Discovery Fund and Novartis Venture Fund
LoQus23 Therapeutics Ltd. (‘LoQus23’), a company discovering small molecule therapies that target aberrant DNA mismatch […]
Chroma Medicine Launches with $125M in Financing to Deliver on the Promise of Epigenetic Editing
Chroma Medicine, Inc., (Chroma) a new genomic medicine company pioneering epigenetic editing, launched today with $125M in […]
ACELYRIN, INC. Closes $250 Million Series B Financing and Announces Licensing of Izokibep, a Late-Stage IL-17A Inhibitor to Treat Inflammatory Diseases
ACELYRIN, INC., an innovative clinical-stage biopharma company that identifies, acquires, and accelerates the development and […]
Government to Invest £375 Million in Neurodegenerative Disease Research
People living with neurodegenerative diseases could live longer, healthier lives due to innovative new research, […]
MyLife Technologies Raises US$4.0 Million to Further Develop its Vaccine Delivery Technology Through Painless Ceramic Vaccine Patches for 'Pandemic Preparedness'
MyLife Technologies, a Dutch vaccine and drug delivery company, focusing on the development of ceramic […]
Olympus Launches Venture Capital Fund to Strengthen Medtech Leadership
Olympus Corporation (Tokyo: 7733), a global leader in medical technology, has announced the establishment of […]
Compugen Announces Collaboration Expansion with Bristol Myers Squibb Alongside $20 Million Equity Investment
Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more